C1 Inhibitor (Recombinant) and Thromboembolism
Result of checking the interaction of drug C1 Inhibitor (Recombinant) and disease Thromboembolism for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Serious arterial and venous thromboembolic (TE) events have been reported at the recommended dose of plasma derived conestat alfa. Patients with risk factors such as, prior history of thrombosis might be at an increased risk. It is recommended to monitor patients with known risk factors for TE events during and after therapy administration.
Generic Name: conestat alfa
Brand Name: Ruconest
Synonyms: Conestat alfa